
NEMLUVIO
Generic Name/API: nemolizumab-ilto
Manufacturer: Galderma Laboratories
Dosage Forms & Strength & Pack Size:
For injection: single-dose pre-filled dual-chamber pen containing 30 mg of nemolizumab-ilto lyophilized powder and diluent, water for injection.
Storage:
Storage and Handling
Store the NEMLUVIO dual chamber prefilled pen in a refrigerator at 36°F to 46°F (2°C to 8°C) in the original carton to protect from light until the expiration date. Do not freeze. Do NOT
expose to heat or direct sunlight.
Alternatively, the NEMLUVIO carton containing the unused dual chamber prefilled pen may be stored at room temperature [up to 77°F (25°C)] for up to 90 days. Write the date the
NEMLUVIO dual chamber prefilled pen is first removed from the refrigerator in the space provided on the inner partition for the pen. Do not use the NEMLUVIO dual chamber prefilled
pen beyond the expiration date or 90 days after the date it was first removed from the refrigerator (whichever is earlier).
- INDICATION
- IMPORTANT SAFETY INFORMATION
Indications: NEMLUVIO® (nemolizumab-ilto) is a prescription medicine used:
- to treat adults and children 12 years of age and older with moderate-to-severe eczema (atopic dermatitis or AD) in combination with prescription therapies used on the skin (topical) when the eczema is not well controlled by topical therapies alone. It is not known if NEMLUVIO is safe and effective in children with atopic dermatitis under 12 years of age.
- to treat adults with prurigo nodularis. It is not known if NEMLUVIO is safe and effective in children with prurigo nodularis under 18 years of age.
Do not take NEMLUVIO if you are allergic to nemolizumab-ilto or to any ingredients in NEMLUVIO. Before taking NEMLUVIO, tell your healthcare provider about all of your medical conditions, including if you:
- are scheduled to receive any vaccination. You should not receive a live vaccine right before or during treatment with NEMLUVIO.
- are pregnant or plan to become pregnant. It is not known whether NEMLUVIO will harm your unborn baby.
- are breastfeeding or plan to breastfeed. It is not known whether NEMLUVIO passes into your breast milk and if it can harm your baby.
Tell your doctor about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.
NEMLUVIO may cause serious side effects, including: allergic reactions (hypersensitivity). Stop using NEMLUVIO and tell your healthcare provider or get emergency help right away if you get any of the following symptoms:
- Breathing problems or wheezing
- Swelling of the face, lips, mouth, tongue, or throat
- Fainting, dizziness, feeling lightheaded
- Fast pulse
- Swollen lymph nodes
- Joint pain
- Fever
- Skin rash (red or rough skin)
- Nausea or vomiting
- General ill feeling
- Cramps in your stomach area
The most common side effects of NEMLUVIO include:
- Eczema: headache, joint pain, hives (itchy red rash or wheals), and muscle aches
- Prurigo Nodularis: headache and skin rashes: atopic dermatitis (a type of eczema), eczema, and eczema nummular (scattered circular patches)
These are not all of the possible side effects of NEMLUVIO.
*The contents of this site are for reference only. We do not offer drug procurement service. All information must not be used for any commercial purpose.







